Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Henlius Forecasts Profit in 2023: Achieving first full year of profitability, and ushering in a new phase of high-quality development 2024-03-04 21:19
Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting 2024-03-04 16:53
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease 2024-03-04 16:22
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2 2024-03-02 10:26
The 16th Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM Takes Place in Nanyang, China 2024-03-02 05:10
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories 2024-03-01 21:35
Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia 2024-03-01 08:00
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency 2024-02-29 17:40
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease 2024-02-28 21:32
RRD International is now RRD Biopharma Development 2024-02-28 21:00
The 20th International Congress on Luobing Theory Held in Shijiazhuang 2024-02-28 09:37
BioCina and NovaCina Forge Strategic Alliance to Offer Biologics Developers Integrated Drug Substance and Drug Product Solutions 2024-02-28 02:30
Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China 2024-02-27 16:09
Takeda Accelerates Access to its Dengue Vaccine Through 'Make in India' Manufacturing Partnership with Biological E. 2024-02-27 12:40
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis 2024-02-27 07:14
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics 2024-02-27 05:55
OVER HALF OF AUSTRALIAN WOMEN FEEL THEIR PAIN IS IGNORED OR DISMISSED - HIGHLIGHTING NATIONAL GENDER PAIN GAP 2024-02-26 21:01
Encouraging Initial Data from CYP-006TK Diabetic Foot Ulcer Clinical Trial 2024-02-26 14:37
Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies 2024-02-23 18:23
CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy 2024-02-23 15:00
1 6 7 8 9 10 230